Zhicai Zhang
Overview
Explore the profile of Zhicai Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1069
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pu F, Yu Y, Shao Z, Wu W, Feng J, Chen F, et al.
Front Oncol
. 2023 Apr;
13:1115898.
PMID: 37091177
Purpose: To examine clinical outcomes of a specialized modular prosthesis used to fill a bone deficiency following removal of femoral shaft metastases. Methods: Eighteen patients with femoral shaft metastases who...
12.
Yu Y, Li K, Peng Y, Wu W, Chen F, Shao Z, et al.
Front Oncol
. 2023 Apr;
13:1165380.
PMID: 37091152
Cancer metastasis is a major cause of mortality from several tumors, including those of the breast, prostate, and the thyroid gland. Since bone tissue is one of the most common...
13.
Pu F, Yu Y, Zhang Z, Wu W, Shao Z, Li C, et al.
Macromol Biosci
. 2023 Apr;
23(9):e2300032.
PMID: 37088909
Polyetheretherketone (PEEK) can potentially be used for bone repair because its elastic modulus is similar to that of human natural bone and good biocompatibility and chemical stability. However, its hydrophobicity...
14.
Pu F, Yu Y, Zhang Z, Liu J, Shao Z, Chen F, et al.
Mol Clin Oncol
. 2023 Mar;
18(4):27.
PMID: 36908975
There is no unified surgical plan for fibular proximal malignant tumours; therefore, the present study retrospectively analysed the medical records of 19 patients with primary malignant and invasive tumours in...
15.
Huang X, Guo H, Wang L, Zhang Z, Zhang W
Drug Discov Today
. 2023 Feb;
28(4):103514.
PMID: 36736580
Small interfering RNA (siRNA) therapeutics for cancer are a focus of increasing research interest. However, the major obstacle to their clinical application is the targeted delivery of siRNA to cancer...
16.
Jing D, Chen X, Zhang Z, Chen F, Huang F, Zhang Z, et al.
Mol Med
. 2023 Jan;
29(1):15.
PMID: 36717782
Background: Osteosarcoma is a malignant bone tumor that usually affects adolescents aged 15-19 y. The DNA damage response (DDR) is significantly enhanced in osteosarcoma, impairing the effect of systemic chemotherapy....
17.
Liu W, Hu H, Shao Z, Lv X, Zhang Z, Deng X, et al.
Bone Res
. 2023 Jan;
11(1):4.
PMID: 36596773
The immune microenvironment extensively participates in tumorigenesis as well as progression in osteosarcoma (OS). However, the landscape and dynamics of immune cells in OS are poorly characterized. By analyzing single-cell...
18.
Cao L, Wu W, Deng X, Peng Y, Chen Y, Guo H, et al.
Front Genet
. 2022 Nov;
13:1000515.
PMID: 36386816
In several tumors, Nicotinamide N-Methyltransferase (NNMT) was identified as a bridge between methylation metabolism and tumorigenesis and was associated with a poor prognosis. This research aims is to study the...
19.
Wu W, Guo H, Jing D, Zhang Z, Zhang Z, Pu F, et al.
Adv Healthc Mater
. 2022 Sep;
11(23):e2200955.
PMID: 36123781
Osteosarcoma is a rare malignant bone-originating tumor that usually occurs in young people. Programmed cell death 1 ligand 1 (PD-L1), an immune checkpoint protein, is highly expressed in osteosarcoma tissues....
20.
Pu F, Wu W, Jing D, Yu Y, Peng Y, Liu J, et al.
Biomater Transl
. 2022 Sep;
3(2):134-141.
PMID: 36105569
Reconstruction after resection has always been an urgent problem in the treatment of bone tumours. There are many methods that can be used to reconstruct bone defects; however, there are...